News | November 03, 2021
Covaxin shelf-life extended to 12 months from the date of manufacture
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
It is a recombinant nanoparticle protein-based vaccine
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
The trial will be conducted across eight sites in Maharashtra
The trial will be conducted across 10 sites in India
CDSCO gives the green signal as HGCO19 was safe, tolerable and immunogenic in the participants of the study
Subscribe To Our Newsletter & Stay Updated
